As electronics manufacturer Philips struggles to cope with its second medical device recall of the year, the news regarding its first recall has just gotten significantly worse. Earlier this year, a variety of Philips ventilators, BiPAP, and CPAP machines were taken out of service and recalled over concerns that the sound-deadening foam used to insulate the machines and make them quieter could enter the breathing circuit and allow ...
Philips Device Recall Expands with Cancer Risk Warnings
Posted August 24, 2021 in Drug and Medical Device Lawsuits | Product News and Recalls
Roundup Cancer Trial Jury Finds Glyphosate Responsible for Man’s Cancer
Posted March 28, 2019 in Product News and Recalls | roundup
A San Francisco jury finds Roundup caused a man’s cancer just as it was about to enter its second week of deliberations. In the second Roundup cancer trial to be heard in a courtroom, final arguments in Edwin Hardeman’s case against the manufacturer (Monsanto was purchased by Bayer for $63 billion) were delivered last week and the jury had been deliberating since. As those closely watching ...
Roundup Cancer Case Seeks to Prove Monsanto Coverup
Posted June 7, 2018 in Product News and Recalls | roundup
A groundskeeper in California may be poised to shine a brighter light on Monsanto’s operations than the company has ever faced thanks to a judge’s order that removed a key element of the corporation’s veil of secrecy. The victim’s lawsuit not only seeks to prove that the glyphosate found in Roundup caused his cancer but also that Monsanto has known about the dangers ...
Intravenous Cancer Drug Now Carries Risk of Stevens-Johnson Syndrome
Posted August 1, 2017 in Drug and Medical Device Lawsuits | Product News and Recalls
First Word Pharma carries word of a health warning issued to cancer patients and their healthcare professionals regarding Aranesp; as the drug now carries the risk of Stevens-Johnson syndrome, as well as other severe side effects.
Stevens-Johnson syndrome is a potentially life-threatening condition, and use of Aranesp should be discontinued immediately if SJS symptoms develop. Patients may at first exhibit flu-like symptoms such as fever, exhaustion, and ...
continue reading...Jury Finds Definitive Link Between Johnson & Johnson Talc and Cancer
Posted March 8, 2016 in Product News and Recalls
In a first of its kind decision, a St. Louis jury not only found that evidence indicated that Johnson & Johnson talcum powder caused a woman’s fatal ovarian cancer but also that the company knew about the possible dangers associated with its use. The jury found that Johnson & Johnson completely failed to act on this information and was ordered to pay some $72 million ...
New Tool Compares Costs and Potential Benefits of Cancer Treatments
Posted October 11, 2015 in Product News and Recalls
A long-awaited tool has been developed by the National Comprehensive Cancer Network (NCCN) to assist patients in evaluating and comparing the costs and benefits of different cancer therapies. As oncology treatment becomes increasingly diverse and expensive, patients require more precise and calculated evaluation of treatment options, including an understanding of both the risks and benefits, as well as the potential financial costs associated with their treatment options. A ...
